JNJ

190.31

-0.15%↓

ABT

127.15

+0.3%↑

MDT

94.09

+0.34%↑

VEEV

295.48

+0.77%↑

A

146.74

-0.99%↓

JNJ

190.31

-0.15%↓

ABT

127.15

+0.3%↑

MDT

94.09

+0.34%↑

VEEV

295.48

+0.77%↑

A

146.74

-0.99%↓

JNJ

190.31

-0.15%↓

ABT

127.15

+0.3%↑

MDT

94.09

+0.34%↑

VEEV

295.48

+0.77%↑

A

146.74

-0.99%↓

JNJ

190.31

-0.15%↓

ABT

127.15

+0.3%↑

MDT

94.09

+0.34%↑

VEEV

295.48

+0.77%↑

A

146.74

-0.99%↓

JNJ

190.31

-0.15%↓

ABT

127.15

+0.3%↑

MDT

94.09

+0.34%↑

VEEV

295.48

+0.77%↑

A

146.74

-0.99%↓

Search

Certara Inc

Închisă

SectorSănătate

12.52 -1.11

Rezumat

Modificarea prețului

24h

Curent

Minim

12.4

Maxim

12.93

Indicatori cheie

By Trading Economics

Venit

-6.7M

-2M

Vânzări

-1.4M

105M

P/E

Medie Sector

246.2

37.461

Marjă de profit

-1.882

Angajați

1,487

EBITDA

29M

30M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+21.09% upside

Dividende

By Dow Jones

Următoarele câștiguri

6 nov. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

365M

2B

Deschiderea anterioară

13.63

Închiderea anterioară

12.52

Sentimentul știrilor

By Acuity

100%

0%

361 / 373 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Very Strong Bearish Evidence

Certara Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

27 oct. 2025, 23:32 UTC

Achiziții, Fuziuni, Preluări

CSL Delays Flu-Vaccine Spinoff, Cuts Guidance As U.S. Vaccination Rates Decline

27 oct. 2025, 23:00 UTC

Achiziții, Fuziuni, Preluări

Australia's AUB Opens Books to EQT After Receiving $3.44 Billion Takeover Offer

27 oct. 2025, 21:42 UTC

Câștiguri

Waste Management 3Q Revenue Climbs, Sees Fiscal Year Revenue at Low End of Prior View

27 oct. 2025, 23:43 UTC

Market Talk

Nikkei May Rise on Easing U.S.-China Trade Tensions -- Market Talk

27 oct. 2025, 23:42 UTC

Market Talk

Gold Rises on Likely Technical Recovery -- Market Talk

27 oct. 2025, 23:37 UTC

Market Talk

Investors May Cheer CSL's Decision to Delay Seqirus Spinoff -- Market Talk

27 oct. 2025, 23:00 UTC

Câștiguri

The Good Vibes Are Back on Wall Street -- WSJ

27 oct. 2025, 22:45 UTC

Achiziții, Fuziuni, Preluări

Australia's AUB Opens Books to EQT After Receiving $3.44B Takeover Offer

27 oct. 2025, 22:06 UTC

Market Talk
Câștiguri

Nucor Expects Weaker Steel Market in 4Q -- Market Talk

27 oct. 2025, 22:05 UTC

Câștiguri

China Southern Airlines: Continued Improvements in Business Environment Supported Results >1055.HK

27 oct. 2025, 22:04 UTC

Câștiguri

Cadence Reports Solid Earnings. The Stock Is Falling. -- Barrons.com

27 oct. 2025, 22:04 UTC

Câștiguri

China Southern Airlines 3Q Net CNY3.84B, Up 20.3% on Year >1055.HK

27 oct. 2025, 22:03 UTC

Câștiguri

China Southern Airlines 3Q Rev CNY51.37B, Up 3.0% on Year >1055.HK

27 oct. 2025, 21:27 UTC

Câștiguri

Waste Management 3Q Rev Climbs, Sees FY Rev at Low End of Prior View

27 oct. 2025, 21:19 UTC

Câștiguri

Cadence Reports Solid Earnings. The Stock Is Falling. -- Barrons.com

27 oct. 2025, 20:50 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Health Care Roundup: Market Talk

27 oct. 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

27 oct. 2025, 20:37 UTC

Câștiguri

Waste Management: Decrease From Prior Rev Expectations Is Primarily Related to Further Decline in Recycled Commodity Pricing, Modestly Lower Rev Expectations From Healthcare Solutions >WM

27 oct. 2025, 20:37 UTC

Câștiguri

Waste Management: 2025 Free Cash Flow Guidance Remains Between $2.8B and $2.9B >WM

27 oct. 2025, 20:37 UTC

Câștiguri

Waste Management: 2025 Total Co Rev Is Now Expected Approximately $25.275B >WM

27 oct. 2025, 20:37 UTC

Câștiguri

Waste Management: Affirming 2025 Adjusted Operating EBITDA Guidance Between $7.475B and $7.625B >WM

27 oct. 2025, 20:31 UTC

Câștiguri

Nucor Sees 4Q Earnings Lower Than 3Q

27 oct. 2025, 20:30 UTC

Câștiguri

Nucor 3Q Steel Mills Total Shipments 6.43M Tons >NUE

27 oct. 2025, 20:30 UTC

Câștiguri

Nucor 3Q EPS $2.63 >NUE

27 oct. 2025, 20:30 UTC

Câștiguri

Nucor 3Q Net $607M >NUE

27 oct. 2025, 20:30 UTC

Câștiguri

Nucor 3Q Sales $8.52B >NUE

27 oct. 2025, 20:30 UTC

Câștiguri

Nucor 3Q Total Tons Shipped to Outside Customers Down 1% >NUE

27 oct. 2025, 20:30 UTC

Câștiguri

Waste Management 3Q Adj EPS $1.98 >WM

27 oct. 2025, 20:30 UTC

Câștiguri

Waste Management 3Q Rev $6.44B >WM

27 oct. 2025, 20:30 UTC

Câștiguri

Waste Management 3Q Net $603M >WM

Comparație

Modificare preț

Certara Inc Așteptări

Obiectiv de preț

By TipRanks

21.09% sus

Prognoză pe 12 luni

Medie 15.33 USD  21.09%

Maxim 16 USD

Minim 13 USD

În baza a 8 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruCertara Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

8 ratings

5

Cumpărare

3

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

11.27 / 12.79Suport & Rezistență

Termen scurt

Very Strong Bearish Evidence

Termen mediu

Very Strong Bullish Evidence

Termen lung

Strong Bullish Evidence

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Certara Inc

Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics. The company provides Simcyp Simulator, a mechanistic biosimulation platform mechanistic biosimulation investigational new drug and translational stages; Simcyp Biopharmaceutics, used to identify and refine drug formulations; and Simcyp Secondary Intelligence which integrates toxicology with quantitative analysis of networks of molecular and functional biological changes to identify drug toxicity and adverse drug reactions. In addition, it offers Phoenix WinNonlin, a platform for non-compartmental analysis, pharmacokinetic/pharmacodynamic, and toxicokinetic; phoenix hosted, that provides a secured and validated certara amazon web services workspace; Phoenix NLME, a population modeling and simulation software for nonlinear mixed effects models; and pirana modeling workbench. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange, used to define data standards and specifications; and Metadata Repository, to enable study design using controlled and standardized data. It serves life sciences companies, biopharmaceutical companies, research organizations, academic institutions, and global regulators, as well as animal health, crop science, bio science, medical devices, and public sector industries. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.
help-icon Live chat